![Robert A. Drakas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert A. Drakas
No open positions remaining
Profile
Robert A. Drakas is currently the Chief Executive Officer & Director at Rila Therapeutics, Inc. He is also the Executive Director at Shangpharma Corp., the Director at Azkarra Therapeutics, Inc., the President at ShangPharma Innovation, Inc., and a Board Member at Blue Oak Pharmaceuticals, Inc. Previously, he held positions as the Senior Director-Business Development at Shanghai ChemPartner Co., Ltd. and the Vice President at Merck & Co., Inc. Drakas obtained a doctorate degree from Thomas Jefferson University, a graduate degree from Drexel University, and an undergraduate degree from the University of Scranton.
Robert A. Drakas active positions
| Companies | Position | Start |
|---|---|---|
ShangPharma Innovation, Inc.
 ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Director/Board Member | 2020-05-31 |
Azkarra Therapeutics, Inc.
 Azkarra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical research and development company that provides oncology therapies based on DNA damage response | Director/Board Member | 2021-01-31 |
Blue Oak Pharmaceuticals, Inc.
 Blue Oak Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for brain disorders | Director/Board Member | 2020-01-31 |
Shangpharma Corp.
 Shangpharma Corp. BiotechnologyHealth Technology Operates as a pharmaceutical and biotechnology research & development outsourcing company | Corporate Officer/Principal | 2016-03-31 |
Former positions of Robert A. Drakas
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Shanghai ChemPartner Co., Ltd.
 Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Corporate Officer/Principal | - |
Training of Robert A. Drakas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
 University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shangpharma Corp.
Shangpharma Corp. BiotechnologyHealth Technology Operates as a pharmaceutical and biotechnology research & development outsourcing company | Health Technology |
Shanghai ChemPartner Co., Ltd.
Shanghai ChemPartner Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization | Commercial Services |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation invests in companies located in the United States. The firm targets companies operating in the fields of healthcare sector. It provides financing for seed to early stage capital requirements. | Finance |
Blue Oak Pharmaceuticals, Inc.
Blue Oak Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for brain disorders | Health Technology |
Azkarra Therapeutics, Inc.
Azkarra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a medical research and development company that provides oncology therapies based on DNA damage response | Commercial Services |
- Stock Market
- Insiders
- Robert A. Drakas
